New diabetes clinical trial: Triple Therapy in T1DM

Published on: April 02, 2019 at 07:00PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Insulin;   Drug: Semaglutide;   Drug: Dapagliflozin;   Drug: Placebo to Dapagliflozin
Sponsors:   State University of New York at Buffalo;   University of Glasgow
Not yet recruiting